BlackRock Institutional Trust’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock Institutional Trust’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$20.5M	Buy	1,156,601 +52,385	+5%	+$920K	﹤0.01%	1948
2016 Q3	$21.3M	Buy	1,104,216 +4,788	+0.4%	+$93.7K	﹤0.01%	1849
2016 Q2	$21.4M	Sell	1,099,428 -18,642	-2%	-$366K	﹤0.01%	1806
2016 Q1	$23M	Buy	1,118,070 +15,697	+1%	+$309K	﹤0.01%	1728
2015 Q4	$22.6M	Buy	1,102,373 +15,933	+1%	+$305K	﹤0.01%	1778
2015 Q3	$18.6M	Sell	1,086,440 -11,526	-1%	-$211K	﹤0.01%	1892
2015 Q2	$20.5M	Sell	1,097,966 -56,583	-5%	-$1.05M	﹤0.01%	1911
2015 Q1	$22M	Buy	1,154,549 +27,491	+2%	+$508K	﹤0.01%	1865
2014 Q4	$18.6M	Sell	1,127,058 -5,980	-0.5%	-$103K	﹤0.01%	1964
2014 Q3	$20M	Sell	1,133,038 -61,397	-5%	-$1.21M	﹤0.01%	1864
2014 Q2	$24.7M	Sell	1,194,435 -889	-0.1%	-$18.3K	﹤0.01%	1813
2014 Q1	$26M	Sell	1,195,324 -60,615	-5%	-$1.39M	﹤0.01%	1787
2013 Q4	$33.3M	Buy	1,255,939 +74,919	+6%	+$1.84M	0.01%	1556
2013 Q3	$27.9M	Sell	1,181,020 -24,491	-2%	-$572K	0.01%	1612
2013 Q2	$25.9M	Buy	+1,205,511	New	+$26M	0.01%	1605

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

BlackRock Institutional Trust's VIVO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Meridian Bioscience Inc (VIVO) stake by 4.7% in Q4 2016, buying an estimated $920K and bringing the position to 1,156,601 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

BlackRock Institutional Trust first reported a position in VIVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $33.3M in Q4 2013. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

BlackRock Institutional Trust held 1,156,601 shares of Meridian Bioscience Inc worth $20.5M as of Q4 2016.
BlackRock Institutional Trust bought 52,385 Meridian Bioscience Inc shares in Q4 2016, an estimated $920K.
Meridian Bioscience Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1948 holding.
BlackRock Institutional Trust first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Meridian Bioscience Inc position peaked at $33.3M in Q4 2013.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.